These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37545515)

  • 1. Intranasal immunization with a Bucl8-based vaccine ameliorates bacterial burden and pathological inflammation, and promotes an IgG2a/b dominant response in an outbred mouse model of
    Grund M; Choi SJ; Powell L; Lukomski S
    Front Immunol; 2023; 14():1177650. PubMed ID: 37545515
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LVS Δ
    Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC.
    Schmidt LK; Orne CE; Shaffer TL; Wilson SM; Khakhum N; Torres AG; Brett PJ; Burtnick MN
    Infect Immun; 2022 Aug; 90(8):e0022222. PubMed ID: 35862715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.
    Burtnick MN; Shaffer TL; Ross BN; Muruato LA; Sbrana E; DeShazer D; Torres AG; Brett PJ
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109172
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucosal Vaccination With Recombinant
    Wei J; Hegde VL; Yanamandra AV; O'Hara MP; Keegan B; Jones KM; Strych U; Bottazzi ME; Zhan B; Sastry KJ; Hotez PJ
    Front Immunol; 2022; 13():800295. PubMed ID: 35197976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.
    Nieves W; Petersen H; Judy BM; Blumentritt CA; Russell-Lodrigue K; Roy CJ; Torres AG; Morici LA
    Clin Vaccine Immunol; 2014 May; 21(5):747-54. PubMed ID: 24671550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.
    Scott AE; Laws TR; D'Elia RV; Stokes MG; Nandi T; Williamson ED; Tan P; Prior JL; Atkins TP
    Clin Vaccine Immunol; 2013 Jul; 20(7):1041-7. PubMed ID: 23677322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and Experimental Immunogenicity of
    Grund ME; Kramarska E; Choi SJ; McNitt DH; Klimko CP; Rill NO; Dankmeyer JL; Shoe JL; Hunter M; Fetterer DP; Hedrick ZM; Velez I; Biryukov SS; Cote CK; Berisio R; Lukomski S
    Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835150
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.
    Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL
    Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA
    Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
    Pacini MF; Balbi CB; Dinatale B; González FB; Prochetto E; De Hernández MA; Cribb P; Farré C; Espariz M; Blancato VS; Magni C; Marcipar I; Pérez AR
    Acta Trop; 2023 May; 241():106889. PubMed ID: 36893830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.
    Healey GD; Elvin SJ; Morton M; Williamson ED
    Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis.
    Schully KL; Bell MG; Prouty AM; Gallovic MD; Gautam S; Peine KJ; Sharma S; Bachelder EM; Pesce JT; Elberson MA; Ainslie KM; Keane-Myers A
    Int J Pharm; 2015 Nov; 495(2):849-61. PubMed ID: 26428631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.